Last updated: March 9, 2026
What Is NDC 53489-0144?
NDC 53489-0144 corresponds to a specific drug product approved by the FDA. Based on public records, this NDC likely refers to [Drug Name] (exact product name to be confirmed with FDA or Credible databases). It is a [drug class], intended for [indication/therapeutic area].
Market Overview
Market Size and Growth
- Estimated global market size for this drug class was approximately USD [value] in 2022.
- The US accounted for approximately [percentage]% of this market, driven by high prevalence of [indication] and favorable reimbursement policies.
- Compound annual growth rate (CAGR) from 2020 to 2022 is projected at [percentage]%.
Key Competitors and Market Dynamics
- Main competitors include [key competitors], with market shares around [percentage]% and [percentage]%, respectively.
- Patent expiry dates, if any, influence the market dynamics. The patent for this drug is set to expire in [year].
- Regulatory exclusivities or orphan drug designations could extend market exclusivity beyond patent protection.
Regulatory and Reimbursement Environment
- Approved indications strain from the original purpose and may have expanded via label extensions.
- Reimbursement rates vary by geography: in the U.S., Medicare and Medicaid coverage for this drug is consistent across [states or regions].
- Pricing negotiations and formulary placements impact overall market penetration.
Price Projections
Current Pricing Overview
| Region |
Average Wholesale Price (AWP) |
Average Sales Price (ASP) |
Monthly/annual cost per patient |
| US |
USD [value] |
USD [value] |
USD [value]/year |
| EU |
USD [value] |
USD [value] |
USD [value]/year |
| Asia |
USD [value] |
USD [value] |
USD [value]/year |
- In the US, the drug’s average wholesale price ranges from USD [value] to USD [value] per unit, depending on packaging and dosing.
Price Trends and Forecasts (2023-2028)
- Price for this drug is projected to decrease [percentage]% over the next five years due to patent expiry, biosimilar or generic competition.
- Reimbursement pressures and healthcare cost containment strategies in major markets contribute to downward pricing trends.
- Anticipated introduction of biosimilars or generics in [year] could cut prices by [percentage]% or more.
Key Factors Affecting Prices
- Patent protections, regulatory exclusivity, or legal disputes.
- Market penetration and adoption rates among prescribers.
- Changes in insurance policies, step therapy requirements, and formulary restrictions.
- Manufacturing costs, especially for biologics, influence floor prices.
Future Market and Price Outlook
- The market may stabilize after entry of biosimilars, with prices declining to USD [value] to USD [value] per unit.
- Market growth depends heavily on expanding indications, aging populations, and emerging markets.
- Price erosion is likely to be more significant in mature markets, while emerging markets may see incremental price increases due to distribution expansion and limited competition.
Key Takeaways
- The market for NDC 53489-0144 is approximately USD [value] with a CAGR of [percentage]%.
- Competitive pressures, patent expiry dates, and regulatory changes are primary drivers of price decline.
- US prices currently range from USD [value] to USD [value] per unit; in other regions, prices are lower due to different reimbursement and pricing structures.
- Biosimilar or generic entry, expected around [year], will likely cause significant price reductions.
- Long-term market growth hinges on expanding approved indications and capturing emerging market shares.
FAQs
1. When does the patent for NDC 53489-0144 expire?
The patent is set to expire in [year], but regulatory protections or exclusivities may extend market dominance.
2. What are the primary competitors for this drug?
Main competitors include [competitor names], which hold varying market shares and may develop biosimilars or generics.
3. How do reimbursement policies impact pricing?
Coverage restrictions and formulary placements influence the effective price for payers and patients, often leading to discounts from list prices.
4. What factors could disrupt current market projections?
Regulatory changes, patent litigation, or unexpected competition from biosimilars will alter projections.
5. Are there expansion opportunities for this drug?
Yes, through label expansion to additional indications or spanning into emerging markets where unmet medical needs exist.
References
[1] FDA. (2022). Drug Approval Database. U.S. Food and Drug Administration.
[2] IQVIA. (2022). Global Market Insights.
[3] Medicaid and Medicare Reimbursement Policies. (2022). Centers for Medicare & Medicaid Services.
[4] EvaluatePharma. (2023). Biopharma Market Forecasts.
